Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Topoisomerase II, specifically DNA gyrase, is a type II topoisomerase enzyme found primarily in prokaryotes. It introduces negative supercoils into double-stranded closed-circular DNA using energy from ATP hydrolysis, playing a critical role in maintaining the underwound state of bacterial genomes and facilitating DNA replication and transcription. It is an essential bacterial enzyme and a target for fluoroquinolone antibiotics.
Inhibition of DNA gyrase activity, leading to double-strand breaks and disruption of DNA replication and transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Topoisomerase II (DNA gyrase) (Gyrase).